Torre, P.; Motta, B.M.; Sarcina, T.; Festa, M.; Masarone, M.; Persico, M.
Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers. Int. J. Mol. Sci. 2025, 26, 8426.
https://doi.org/10.3390/ijms26178426
AMA Style
Torre P, Motta BM, Sarcina T, Festa M, Masarone M, Persico M.
Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers. International Journal of Molecular Sciences. 2025; 26(17):8426.
https://doi.org/10.3390/ijms26178426
Chicago/Turabian Style
Torre, Pietro, Benedetta Maria Motta, Tommaso Sarcina, Mariano Festa, Mario Masarone, and Marcello Persico.
2025. "Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers" International Journal of Molecular Sciences 26, no. 17: 8426.
https://doi.org/10.3390/ijms26178426
APA Style
Torre, P., Motta, B. M., Sarcina, T., Festa, M., Masarone, M., & Persico, M.
(2025). Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers. International Journal of Molecular Sciences, 26(17), 8426.
https://doi.org/10.3390/ijms26178426
